1. Each of the plaintiffs' claims against the defendants is dismissed.

2. The costs of lawsuit are assessed against the plaintiffs.

1. Facts of recognition;

A. Defendant L Co., Ltd. (hereinafter “Defendant Co., Ltd.”) sells cosmetics at a multilevel. Defendant M is a representative director of Defendant Co., Ltd. who is in charge of overall administrative affairs, Defendant N is a person planning and exercising overall control over the payment system as an actual operator of Defendant Co., Ltd., and Defendant N, DefendantO, and P are the vice president of Defendant Co., Ltd., and advisory director at the business presentation held by the headquarters and the branch office nationwide, and manages business organizations such as attracting sales participation.

(hereinafter referred to as “Defendant 4”). (B) The remainder of the Defendants except the Defendant Company.

From June 2012 to January 2013, the Plaintiffs concluded a contract with the Defendant Company as assistant multi-stage salesmen of the Defendant Company, each of which the Plaintiff opened a store, supplied Q products from the Defendant Company, sold them to consumers, and recruited assistant multi-stage salesmen.

(hereinafter “each contract of this case”). (c)

Under each of the instant contracts, the Plaintiffs leased their respective stores and sold signboards, interior works, etc., and Q products supplied by the Defendant Company after being supplied with them.

[Ground of recognition] Facts without dispute, Gap evidence Nos. 1, 4, 5, 6, and 7 (including all types of numbers; hereinafter the same shall apply), witness R's testimony, the purport of the whole pleadings

2. Defendant 4, who is the actual operator or executive officers of the Defendant Company and the Defendant Company, exaggerated publicity of Q Q products with more effective and quality compared to other products using QDT method, and explained that Q products would use Q products as a curative method and PDT method, and that the establishment and operation of a franchise shop selling it would, if any, support human test costs and supply Q Q products at low cost, thereby making the Plaintiffs be able to sell them and make profits from the sale thereof.

The Plaintiffs are above.